Back to Search Start Over

Improving response to olaparib in uterine serous cancer through treatment with AVB500, a receptor tyrosine kinase AXL inhibitor

Authors :
M.D. Toboni
M.M. Mullen
J.I. Tankou
H. Noia
A. Oplt
D. Wilke
P. Cannon
L.M. Kuroki
A.R. Hagemann
C.K. McCourt
P.H. Thaker
D.G. Mutch
M.A. Powell
K.C. Fuh
Source :
Gynecologic Oncology. 159:224-225
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Subjects

Subjects :
Oncology
Obstetrics and Gynecology

Details

ISSN :
00908258
Volume :
159
Database :
OpenAIRE
Journal :
Gynecologic Oncology
Accession number :
edsair.doi...........c9768a8d4459a0caa7d5618b8e928800
Full Text :
https://doi.org/10.1016/j.ygyno.2020.05.373
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details